149 related articles for article (PubMed ID: 20134111)
1. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology of voiding dysfunction and pharmacological therapy.
Takeda M; Araki I; Mochizuki T; Nakagomi H; Kobayashi H; Sawada N; Zakohji H
J Pharmacol Sci; 2010; 112(2):121-7. PubMed ID: 20134111
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic perspective on the physiology of the lower urinary tract.
Andersson KE; Hedlund P
Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic receptor targets for lower urinary tract dysfunction.
Yoshimura N; Kaiho Y; Miyazato M; Yunoki T; Tai C; Chancellor MB; Tyagi P
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):437-48. PubMed ID: 18034230
[TBL] [Abstract][Full Text] [Related]
4. Applied anatomy and physiology of the feline lower urinary tract.
Fletcher TF
Vet Clin North Am Small Anim Pract; 1996 Mar; 26(2):181-96. PubMed ID: 8711856
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology.
Andersson KE; Persson K
Scand J Urol Nephrol Suppl; 1995; 175():43-53. PubMed ID: 8771275
[TBL] [Abstract][Full Text] [Related]
6. Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.
Ruggieri MR; Braverman AS; Pontari MA
J Urol; 2005 Nov; 174(5):1743-8. PubMed ID: 16217275
[TBL] [Abstract][Full Text] [Related]
7. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?
Michel MC
J Pharmacol Sci; 2010; 112(2):151-7. PubMed ID: 20134112
[TBL] [Abstract][Full Text] [Related]
8. Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.
Yamaguchi O
Int J Urol; 2013 Jan; 20(1):28-39. PubMed ID: 23190275
[TBL] [Abstract][Full Text] [Related]
9. [Lower urinary tract function and its disorders].
Zachoval R; Záleský M; Lukes M; Mares J; Urban M; Palascak P
Cesk Fysiol; 2000 Aug; 49(3):134-44. PubMed ID: 11039243
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.
Hegde SS; Eglen RM
Life Sci; 1999; 64(6-7):419-28. PubMed ID: 10069505
[TBL] [Abstract][Full Text] [Related]
11. Storage and voiding symptoms: pathophysiologic aspects.
Andersson KE
Urology; 2003 Nov; 62(5 Suppl 2):3-10. PubMed ID: 14662401
[TBL] [Abstract][Full Text] [Related]
12. Neurotransmitters and neuroreceptors in the lower urinary tract.
Andersson KE
Curr Opin Obstet Gynecol; 1996 Oct; 8(5):361-5. PubMed ID: 8941435
[TBL] [Abstract][Full Text] [Related]
13. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
Andersson KE
Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of continence and micturition.
Bissada NK; Finkbeiner AE
Am Fam Physician; 1979 Nov; 20(5):128-36. PubMed ID: 40428
[TBL] [Abstract][Full Text] [Related]
15. Effects of inhibition of the L-arginine/nitric oxide pathway in the rat lower urinary tract in vivo and in vitro.
Persson K; Igawa Y; Mattiasson A; Andersson KE
Br J Pharmacol; 1992 Sep; 107(1):178-84. PubMed ID: 1422571
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of continence and voiding, with international continence society classification of dysfunction.
Walters MD
Obstet Gynecol Clin North Am; 1989 Dec; 16(4):773-85. PubMed ID: 2697813
[TBL] [Abstract][Full Text] [Related]
17. Regulatory Effects of 5-Hydroxytryptamine Receptors on Voiding Function.
Matsumoto-Miyai K; Yoshizumi M; Kawatani M
Adv Ther; 2015 Oct; 32 Suppl 1():3-15. PubMed ID: 26391372
[TBL] [Abstract][Full Text] [Related]
18. Modulation of voiding and storage reflexes by activation of alpha1-adrenoceptors.
de Groat WC; Yoshiyama M; Ramage AG; Yamamoto T; Somogyi GT
Eur Urol; 1999; 36 Suppl 1():68-73. PubMed ID: 10393477
[TBL] [Abstract][Full Text] [Related]
19. Neural mechanisms underlying lower urinary tract dysfunction.
Yoshimura N; Ogawa T; Miyazato M; Kitta T; Furuta A; Chancellor MB; Tyagi P
Korean J Urol; 2014 Feb; 55(2):81-90. PubMed ID: 24578802
[TBL] [Abstract][Full Text] [Related]
20. The neurological organization of micturition.
Seth JH; Panicker JN; Fowler CJ
Handb Clin Neurol; 2013; 117():111-7. PubMed ID: 24095120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
